Metagenomi Management
Management criteria checks 1/4
Metagenomi's CEO is Brian Thomas, appointed in Sep 2016, has a tenure of 8.17 years. total yearly compensation is $7.83M, comprised of 6.6% salary and 93.4% bonuses, including company stock and options. directly owns 6.35% of the company’s shares, worth $5.02M. The average tenure of the management team and the board of directors is 1.8 years and 3.3 years respectively.
Key information
Brian Thomas
Chief executive officer
US$7.8m
Total compensation
| CEO salary percentage | 6.6% |
| CEO tenure | 8.2yrs |
| CEO ownership | 6.4% |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$74m |
| Jun 30 2024 | n/a | n/a | -US$75m |
| Mar 31 2024 | n/a | n/a | -US$77m |
| Dec 31 2023 | US$8m | US$517k | -US$68m |
| Sep 30 2023 | n/a | n/a | -US$64m |
| Jun 30 2023 | n/a | n/a | -US$54m |
| Mar 31 2023 | n/a | n/a | -US$50m |
| Dec 31 2022 | US$2m | US$500k | -US$44m |
Compensation vs Market: Brian's total compensation ($USD7.83M) is above average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Brian's compensation has increased whilst the company is unprofitable.
CEO
Brian Thomas (55 yo)
8.2yrs
Tenure
US$7,825,855
Compensation
Dr. Brian Charles Thomas, Ph. D., is a Co-Founder of Metagenomi, Inc. (Fomerly, Metagenomi Technologies, LLC). He serves as Chairman of the Board of Metagenomi, Inc. since February 2024. He serves as Chief...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 8.2yrs | US$7.83m | 6.35% $ 5.0m | |
| President | 3.8yrs | US$2.51m | 1.56% $ 1.2m | |
| Chief Medical Officer | 1.8yrs | US$2.04m | 0.11% $ 89.9k | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Chief Financial Officer | less than a year | no data | 0.030% $ 23.3k | |
| Chief Investment Officer & Senior VP of Investor Relations | less than a year | no data | 0.30% $ 234.4k | |
| Vice President of Corporate Legal | less than a year | no data | no data | |
| Senior Vice President of Preclinical | 1.8yrs | no data | no data | |
| Head of Discovery | no data | no data | no data |
1.8yrs
Average Tenure
55.5yo
Average Age
Experienced Management: MGX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | less than a year | US$7.83m | 6.35% $ 5.0m | |
| President | no data | US$2.51m | 1.56% $ 1.2m | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.3yrs | US$49.20k | 0.14% $ 108.2k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | no data | no data | no data | |
| Independent Director | 3.9yrs | no data | 2.06% $ 1.6m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
3.3yrs
Average Tenure
57yo
Average Age
Experienced Board: MGX's board of directors are considered experienced (3.3 years average tenure).